Mesa Labs completed the acquisition of Agena Bioscience for $300m.

Mesa Labs, a firm that acquires, develops, manufactures, and markets electronic measurement instruments, completed the acquisition of Agena Bioscience, a developer and manufacturer of genetic analysis systems and reagents, for $300m. “Our robust technology platform along with deep customer partnership has been the foundation of our success. We built our company based on a strong team-oriented values system, and we see a great fit with the Mesa culture. We look forward to working with the Mesa team to expand the applications we deliver and innovate new technologies for clinical genomics," Peter Dansky, Agena CEO.